Tab Application Banner
  • Users Online: 181
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login

Current Issue

April-June 2018| Vol 13| Issue 2

From the Editors Desk

From the editor's desk

Dear Friends, This issue of the Journal has an interesting brief report appraising the rheumatology training in India and United Kingdom (see article by Das et al. in this issue). Although both cou...


Rheumatology training in India: Pragmatism needed

Over the 70 years of independent India, medical education has evolved from undergraduate courses, which have origins similar to those in the United Kingdom (UK),[1] to postgraduate specialty trainin...


Rheumatology training in India and the UK: Time for a unified and bespoke approach

The healthcare and training needs in India and the United Kingdom, from a Rheumatology perspective, are significantly different. This informs the organization and delivery of training programs in eith...

Original Article

A prospective, randomized, double-blind, comparative clinical study of efficacy and safety of a biosimilar adalimumab with innovator product in patients with active rheumatoid arthritis on a stable dose of methotrexate

Objective: The objective of this study was to compare efficacy, safety, and immunogenicity between the biosimilar adalimumab (AdaliRel) and the reference innovator product in moderate-to-severe...

Original Article

Circulating levels of osteoprotegerin and sRANKL and the effect of methotrexate in patients with rheumatoid arthritis

Background: Receptor activator of nuclear factor κβ ligand (RANKL) and osteoprotegerin (OPG) are pivotal molecules involved in osteoclast activation and resorption. In RA, their alt...

View All Articles in the Current Issue

The Indian Journal of Rheumatology (IJR, formerly, Journal of Indian Rheumatology Association) is the official, peer-reviewed publication of the Indian Rheumatology Association. The Journal is published quarterly (March, June, September, December i.e. 4 issues along with two supplements in November and December every year) by Wolters Kluwer. It is indexed in Scopus and Indmed. It is circulated to all bonafide members of IRA and subscribers.

Thank You Reviewers!

The Editor would like to thank all the reviewers of the Indian Journal of Rheumatology, for generously giving their time and efforts in assessing the manuscripts submitted to the journal.

View Reviewers List

Features of Manuscript Management System

  • Online submission
  • Wider visibility through open access
  • Higher impact
  • Prompt review

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data

The journal is indexed with, or included in, the following:
DOAJ, IndMed, Scimago Journal Ranking, SCOPUS